Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report

S. Goldman, L. Smith, J. R. Anderson, S. Perkins, L. Harrison, M. B. Geyer, T. G. Gross, H. Weinstein, S. Bergeron, B. Shiramizu, W. Sanger, M. Barth, J. Zhi, M. S. Cairo

Research output: Contribution to journal › Letter › peer-review

142 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report'. Together they form a unique fingerprint.